Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of two dose levels of MF59-adjuvanted H5N1 FLUAD-like influenza vaccine in adults and elderly subjects
2005-005871-14Phase 2Completed
- Sponsor
- Chiron Corporation
- Start
- Jun 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of influenza vaccine in avian influenza (HPAI) (2 arms), sponsored by Chiron Corporation. Primary endpoint: Compliance with current European Union recommendations. Started Jun 2006; status: completed.
02
Drugs
influenza vaccine
03
Conditions
avian influenza (HPAI)
Beyond the preview
Go deeper on 2005-005871-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005871-14.